Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 6,965 shares at $45.10 ($315K) on 2024-01-16, disclosed to the SEC on 2024-01-18.
Scheduled sale ($315k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.10 | 2,965 | $134K | 42.5% |
| 2 | $45.10 | 2,965 | $134K | 42.5% |
| 3 | $45.65 | 1,035 | $47K | 15.0% |
| Total | $45.18 avg | 6,965 | $315K | 100% |
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |